Allogene Therapeutics Inc (ALLO)
3.02
-0.05
(-1.63%)
USD |
NASDAQ |
May 06, 16:00
3.005
-0.02
(-0.50%)
After-Hours: 20:00
Allogene Therapeutics Accounts Payable (Quarterly): 5.897M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.897M |
September 30, 2023 | 6.205M |
June 30, 2023 | 10.23M |
March 31, 2023 | 14.69M |
December 31, 2022 | 13.89M |
September 30, 2022 | 11.04M |
June 30, 2022 | 9.713M |
March 31, 2022 | 8.708M |
December 31, 2021 | 10.26M |
September 30, 2021 | 11.50M |
June 30, 2021 | 11.00M |
March 31, 2021 | 14.88M |
Date | Value |
---|---|
December 31, 2020 | 10.39M |
September 30, 2020 | 10.15M |
June 30, 2020 | 9.057M |
March 31, 2020 | 7.199M |
December 31, 2019 | 9.25M |
September 30, 2019 | 8.047M |
June 30, 2019 | 23.50M |
March 31, 2019 | 12.98M |
December 31, 2018 | 12.34M |
September 30, 2018 | 3.083M |
June 30, 2018 | 1.268M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.897M
Minimum
Dec 2023
23.50M
Maximum
Jun 2019
10.82M
Average
10.23M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
Agenus Inc | 61.45M |
ANI Pharmaceuticals Inc | 36.68M |
Vaxart Inc | 1.584M |
aTyr Pharma Inc | 4.893M |
PAVmed Inc | 1.786M |